Viraj Lavingia Vipulkumar Thummar Priya Mehta
10.1177/2050313X221137447
SAGE Open Med Case Rep
2022 Nov 27;10:2050313X221137447.
ado-trastuzumab emtansine biliary tract cancers enhance survival gallbladder cancer human epidermal growth factor receptor 2-positive
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36467008/
Case Reports
PMC9709179
36467008
Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2-overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case study
2022